Urinary delta-ALA: a potential biomarker of exposure and neurotoxic effect in rats co-treated with a mixture of lead, arsenic and manganese.
暂无分享,去创建一个
[1] Justin Bedo,et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. , 2012, Archives of neurology.
[2] P. Baveye,et al. Neurodegenerative diseases and exposure to the environmental metals Mn, Pb, and Hg , 2012 .
[3] M. Aschner,et al. Cellular transport and homeostasis of essential and nonessential metals. , 2012, Metallomics : integrated biometal science.
[4] Hiroshi Ito,et al. Correlation between decreased motor activity and dopaminergic degeneration in the ventrolateral putamen in monkeys receiving repeated MPTP administrations: A positron emission tomography study , 2012, Neuroscience Research.
[5] Jingyuan Chen,et al. Relative contribution of CTR1 and DMT1 in copper transport by the blood-CSF barrier: implication in manganese-induced neurotoxicity. , 2012, Toxicology and applied pharmacology.
[6] M. Aschner,et al. Protective effects of ebselen (Ebs) and para-aminosalicylic acid (PAS) against manganese (Mn)-induced neurotoxicity. , 2012, Toxicology and applied pharmacology.
[7] M. Sauvant-Rochat,et al. What is the best biomarker to assess arsenic exposure via drinking water? , 2012, Environment international.
[8] H. Gamrani,et al. Chronic lead intoxication affects glial and neural systems and induces hypoactivity in adult rat. , 2011, Acta histochemica.
[9] E. Flores,et al. Locomotor damage and brain oxidative stress induced by lead exposure are attenuated by gallic acid treatment. , 2011, Toxicology letters.
[10] M. Valko,et al. Advances in metal-induced oxidative stress and human disease. , 2011, Toxicology.
[11] M. Aschner,et al. Prolactin is a peripheral marker of manganese neurotoxicity , 2011, Brain Research.
[12] S. Batterman,et al. Manganese and lead in children's blood and airborne particulate matter in Durban, South Africa. , 2011, The Science of the total environment.
[13] B. Weiss. Lead, Manganese, and Methylmercury as Risk Factors for Neurobehavioral Impairment in Advanced Age , 2010, International journal of Alzheimer's disease.
[14] Xiao-mei Li,et al. Pathological significance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[15] M. Giordano,et al. Chronic exposure to low levels of inorganic arsenic causes alterations in locomotor activity and in the expression of dopaminergic and antioxidant systems in the albino rat. , 2010, Neurotoxicology and teratology.
[16] Elena I. Queirolo,et al. Prevalence and predictors of exposure to multiple metals in preschool children from Montevideo, Uruguay. , 2010, The Science of the total environment.
[17] C. Peck,et al. A roadmap for biomarker qualification , 2010, Nature Biotechnology.
[18] R. Yokel. Manganese Flux Across the Blood–Brain Barrier , 2009, NeuroMolecular Medicine.
[19] Jing Chen,et al. Manganese exposure among smelting workers: relationship between blood manganese-iron ratio and early onset neurobehavioral alterations. , 2009, Neurotoxicology.
[20] M. Aschner,et al. Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. , 2009, Toxicology and applied pharmacology.
[21] C. Meshram,et al. FP52-FR-03 Neurological complications in manganese mine workers , 2009, Journal of the Neurological Sciences.
[22] W. Wąsowicz,et al. Association between occupational exposure to arsenic and neurological, respiratory and renal effects. , 2009, Toxicology and applied pharmacology.
[23] Etelvino J. H. Bechara,et al. Neurotoxicity and aggressiveness triggered by low-level lead in children: a review. , 2009, Revista panamericana de salud publica = Pan American journal of public health.
[24] M. Cebrián,et al. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. , 2009, Mutation research.
[25] B. Fowler,et al. Roles of biomarkers in evaluating interactions among mixtures of lead, cadmium and arsenic. , 2008, Toxicology and applied pharmacology.
[26] C. Colyer,et al. Manganese exposure alters extracellular GABA, GABA receptor and transporter protein and mRNA levels in the developing rat brain. , 2008, Neurotoxicology.
[27] K. Søreide. Receiver-operating characteristic (ROC) curve analysis in diagnostic, prognostic and predictive biomarker research , 2008 .
[28] P. Heitland,et al. Fast determination of arsenic species and total arsenic in urine by HPLC-ICP-MS: concentration ranges for unexposed german inhabitants and clinical case studies. , 2008, Journal of analytical toxicology.
[29] Donna Bergen. Neurological Disorders: Public Health Challenges , 2007 .
[30] M. Suwalsky,et al. Interaction of arsenic compounds with model phospholipid membranes , 2007 .
[31] A. Akobeng,et al. Understanding diagnostic tests 3: receiver operating characteristic curves , 2007, Acta paediatrica.
[32] P. Landrigan,et al. The Declaration of Brescia on prevention of the neurotoxicity of metals June 18, 2006. , 2006, American journal of industrial medicine.
[33] K. Donnelly,et al. In vitro models for assessing neurotoxicity of mixtures. , 2006, Neurotoxicology.
[34] Sanae Nakagawa,et al. Manganese exposure: neuropsychological and neurological symptoms and effects in welders. , 2006, Neurotoxicology.
[35] Michael Aschner,et al. The transport of manganese across the blood-brain barrier. , 2006, Neurotoxicology.
[36] L. Patrick. Lead toxicity, a review of the literature. Part 1: Exposure, evaluation, and treatment. , 2006, Alternative medicine review : a journal of clinical therapeutic.
[37] M. Mazzetti,et al. Response of glucose metabolism enzymes in an acute porphyria model. Role of reactive oxygen species. , 2005, Toxicology.
[38] Tomás R. Guilarte,et al. Lead neurotoxicity: From exposure to molecular effects , 2005, Brain Research Reviews.
[39] R. Dhaked,et al. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats. , 2005, Life sciences.
[40] G. Scherer. Biomonitoring of inhaled complex mixtures--ambient air, diesel exhaust and cigarette smoke. , 2005, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[41] M. Náray,et al. Behavioral and neurotoxicological effects of subchronic manganese exposure in rats. , 2005, Environmental toxicology and pharmacology.
[42] P. Kakkar,et al. Biological markers for metal toxicity. , 2005, Environmental toxicology and pharmacology.
[43] M. Aschner,et al. Manganese exposure and induced oxidative stress in the rat brain. , 2004, The Science of the total environment.
[44] A M Donoghue,et al. Occupational health hazards in mining: an overview. , 2004, Occupational medicine.
[45] L. Strużyńska,et al. Relationships between glutamine, glutamate, and GABA in nerve endings under Pb-toxicity conditions. , 2004, Journal of inorganic biochemistry.
[46] Rebecca C. Miller,et al. Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. , 2004, Clinical chemistry.
[47] S. Flora,et al. Arsenic induced inhibition of delta-aminolevulinate dehydratase activity in rat blood and its response to meso 2,3-dimercaptosuccinic acid and monoisoamyl DMSA. , 2004, Biomedical and environmental sciences : BES.
[48] M. Giordano,et al. The effects of arsenic exposure on the nervous system. , 2003, Toxicology letters.
[49] M. Basha,et al. Lead induced effects on acetylcholinesterase activity in cerebellum and hippocampus of developing rat , 2003, International Journal of Developmental Neuroscience.
[50] D. Souza,et al. Effects of 5-aminolevulinic acid on the glutamatergic neurotransmission , 2003, Neurochemistry International.
[51] W. Stummer,et al. Transport of 5-aminolevulinic acid between blood and brain , 2003, Brain Research.
[52] Margaret S. Pepe,et al. Semiparametric Receiver Operating Characteristic Analysis to Evaluate Biomarkers for Disease , 2002 .
[53] K. Bundy,et al. Experimental and mathematical/computational assessment of the acute toxicity of chemical mixtures from the Microtox® assay , 2002 .
[54] T. Emanuelli,et al. Effect of mercuric chloride and lead acetate treatment during the second stage of rapid post-natal brain growth on the behavioral response to chlorpromazine and on delta-ALA-D activity in weaning rats. , 2001, Toxicology letters.
[55] E. Moreira,et al. Developmental lead exposure: behavioral alterations in the short and long term. , 2001, Neurotoxicology and teratology.
[56] F. Gil,et al. Biomarkers as biological indicators of xenobiotic exposure , 2001, Journal of applied toxicology : JAT.
[57] M. Caria,et al. Neurotoxic effect of lead at low concentrations , 2001, Brain Research Bulletin.
[58] H. Gurer,et al. Can antioxidants be beneficial in the treatment of lead poisoning? , 2000, Free radical biology & medicine.
[59] M. Ikeda,et al. Blood lead level to induce significant increase in urinary delta-aminolevulinic acid level among lead-exposed workers: a statistical approach. , 2000, Industrial health.
[60] T Sakai,et al. Biomarkers of lead exposure. , 2000, Industrial health.
[61] M. Ikeda,et al. Urinary lead as a possible surrogate of blood lead among workers occupationally exposed to lead , 1999, International archives of occupational and environmental health.
[62] C. Ríos,et al. Effects of lead-arsenic combined exposure on central monoaminergic systems. , 1997, Neurotoxicology and teratology.
[63] D. Souza,et al. Effect of perinatal lead exposure on rat behaviour in open-field and two-way avoidance tasks. , 1996, Pharmacology & toxicology.
[64] D. Souza,et al. Effect of treatment with mercury chloride and lead acetate during the second stage of rapid postnatal brain growth on delta-aminolevulinic acid dehydratase (ALA-D) activity in brain, liver, kidney and blood of suckling rats. , 1995, Toxicology.
[65] M. Kotler,et al. High δ-aminolevulinic acid uptake in rat cerebral cortex: effect on porphyrin biosynthesis , 1995 .
[66] C. Shy,et al. Epidemiological studies of neurotoxic, reproductive, and carcinogenic effects of complex mixtures. , 1993, Environmental health perspectives.
[67] D. Jackson,et al. Role of dopamine and GABA in the control of motor activity elicited from the rat nucleus accumbens , 1991, Pharmacology Biochemistry and Behavior.
[68] Phoon Wh. Manganese exposure and biological indicators. , 1988 .
[69] B. Lagerkvist,et al. Arsenic exposure to smelter workers. Clinical and neurophysiological studies. , 1985, Scandinavian journal of work, environment & health.
[70] D. K. Saxena,et al. Behavioral and neurochemical changes in rats simultaneously exposed to manganese and lead , 1981, Archives of Toxicology.
[71] P. Hammond,et al. Renal reabsorption and secretion of σ-aminolevulinic acid in the ratAA , 1981 .
[72] M. Maines. Regional distribution of the enzymes of haem biosynthesis and the inhibition of 5-aminolaevulinate synthase by manganese in the rat brain. , 1980, The Biochemical journal.
[73] S. Snyder,et al. δ‐Aminolevulinic acid: Influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria , 1977, Annals of neurology.
[74] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[75] J. Arena. Toxicology: The Basic Science of Poisons , 1975 .
[76] M. Ogata,et al. Simple method for determination of urinary -aminolevulinic acid as an index of lead exposure. , 1972, Clinical chemistry.
[77] M. Ehrich,et al. Assessments of tight junction proteins occludin, claudin 5 and scaffold proteins ZO1 and ZO2 in endothelial cells of the rat blood-brain barrier: cellular responses to neurotoxicants malathion and lead acetate. , 2011, Neurotoxicology.
[78] Sanghyuk S. Shin,et al. ROC analysis for the evaluation of continuous biomarkers: Existing tools and new features in SAS® 9.2 , 2009 .
[79] Yngvar Thomassen,et al. A neurobehavioral study of current and former welders exposed to manganese. , 2008, Neurotoxicology.
[80] A. Ferrer. Intoxicación por metales , 2003 .
[81] T. Takata,et al. Relationship between blood lead level and urinary ALA level in workers exposed to very low levels of lead. , 2000, Industrial health.
[82] P. Oteiza,et al. Pb2+ promotes lipid oxidation and alterations in membrane physical properties. , 1999, Toxicology.
[83] E. Bechara,et al. The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyrias. , 1996, Free radical biology & medicine.